Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bacterial Infections and Mycoses

Free Subscription Articles published in Antimicrob Agents Chemother Retrieve available abstracts of 236 articles: HTML format Text format

Single Articles

January 2012
1. KRISTICH CJ , Little JL
   Mutations in the beta subunit of RNA polymerase alter intrinsic cephalosporin resistance in enterococci.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. WARRIER T , Tropis M, Werngren J, Diehl A, et al
   Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. CAMPBELL J , Singh AK, Swoboda JG, Gilmore MS, et al
   An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. VESIC D , Kristich CJ
   MurAA is required for intrinsic cephalosporin resistance of Enterococcus faecalis.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PANTEL A , Petrella S, Veziris N, Brossier F, et al
   Extending GyrB QRDR definition in Mycobacterium tuberculosis DNA gyrase for assessing FQ resistance in M. tuberculosis.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. TAHLAN K , Wilson R, Kastrinsky DB, Arora K, et al
   SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SMYTHE W , Khandelwal A, Merle C, Rustomjee R, et al
   A semi-mechanistic pharmacokinetic-enzyme turn-over model for rifampicin autoinduction in adult tuberculosis patients.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SEAH C , Alexander DC, Louie L, Simor A, et al
   MupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureus.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KELESIDIS T , Chow AL, Humphries R, Uslan DZ, et al
   Comparison Between De-Novo And Daptomycin-Exposed Daptomycin Non-Susceptible Enterococcus Infections: A Case Control Study.
   Antimicrob Agents Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. VALE-SILVA LA , Coste AT, Ischer F, Parker JE, et al
    Azole resistance by loss of function of the sterol {Delta}5,6-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
    Antimicrob Agents Chemother. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. WARRILOW AG , Mullins JG, Hull CM, Parker JE, et al
    S279 Point Mutations in Candida albicans Sterol 14-alpha Demethylase (CYP51) Reduces in vitro Inhibition by Fluconazole.
    Antimicrob Agents Chemother. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. DANBY CS , Boikov D, Rautemaa R, Sobel JD, et al
    Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to eleven antifungal agents - Implications for clinical use.
    Antimicrob Agents Chemother. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KIM SH , Song JH, Chung DR, Thamlikitkul V, et al
    Changing trend of antimicrobial resistance and serotypes in Streptococcus pneumoniae in Asian countries: an ANSORP study.
    Antimicrob Agents Chemother. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. FERNANDEZ J , Abbanat D, Shang W, He W, et al
    Synergistic Activity of Ceftobiprole and Vancomycin in a Rat Model of Infective Endocarditis Caused by Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
    Antimicrob Agents Chemother. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. RUIZ DE GOPEGUI E , Juan C, Zamorano L, Perez JL, et al
    Transferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4' )-Ia and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain.
    Antimicrob Agents Chemother. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
16. HOLMES AR , Keniya MV, Ivnitski-Steele I, Monk BC, et al
    The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SPREGHINI E , Orlando F, Sanguinetti M, Posteraro B, et al
    Comparative analysis of micafungin, caspofungin and anidulafungin against a difficult-to treat fungal opportunistic pathogen: Candida glabrata.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. VERWER PE , van Duijn ML, Tavakol M, Bakker-Woudenberg IA, et al
    Reshuffling of Aspergillus fumigatus cell wall components chitin and beta-glucan under influence of caspofungin and nikkomycin Z alone or in combination.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. LIU Y , Wang Y, Wu C, Shen Z, et al
    First Report of the Multidrug Resistance gene cfr in Enterococcus faecalis of Animal origin.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. WERNGREN J , Sturegard E, Jureen P, Angeby K, et al
    Re-evaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MENDES RE , Woosley LN, Farrell DJ, Sader HS, et al
    Oritavancin Activity against Vancomycin-susceptible and Vancomycin-resistant Enterococci with Molecularly Characterized Glycopeptide Resistance Genes Recovered from Bacteremic Patients (2009 - 2010).
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. WANG Y , Zhang W, Wang J, Wu C, et al
    Distribution of the multidrug resistance gene cfr in Staphylococcus spp. isolates from swine farms in China.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. WIVAGG CN , Hung DT
    Resuscitation-Promoting Factors Are Required for beta-Lactam Tolerance and the Permeability Barrier in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. UCKAY I , Bernard L, Buzzi M, Harbarth S, et al
    High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. TENOVER FC , Tickler IA, Goering RV, Kreiswirth BN, et al
    Characterization of Nares and Blood Culture Isolates of Methicillin-resistant Staphylococcus aureus from Patients in United States Hospitals.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. SANDIFORD S , Upton M
    Identification, characterisation and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis displaying potent activity against staphylococci.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. ROUAN MC , Lounis N, Gevers T, Dillen L, et al
    Pharmacokinetics-Pharmacodynamics of TMC207 and its N-desmethyl Metabolite in a Murine Model of Tuberculosis.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. WATANABE NA , Miyazaki M, Horii T, Sagane K, et al
    E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. BACK EE , O'grady EJ, Back JD
    High rates of perinatal Group B Streptococcus clindamycin and erythromycin resistance in an Upstate NY hospital.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ROY CJ , Sivasubramani SK, Dutta NK, Mehra S, et al
    Aerosolized Gentamicin Reduces the Burden of Tuberculosis in a Murine Model.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. DE GROOTE MA , Gruppo V, Woolhiser LK, Orme IM, et al
    Importance of Confirming in vivo Efficacy Data of Novel Antibacterial Drug Regimens against Various Strains of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
32. BURGEL PR , Baixench MT, Amsellem M, Audureau E, et al
    High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SAKOULAS G , Bayer AS, Pogliano J, Tsuji BT, et al
    Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. LIU Z , Nachamkin I, Edelstein PH, Lautenbach E, et al
    Serotype Emergence and Genotype Distribution among Macrolide Resistant Invasive Streptococcus Pneumoniae in the Post-Conjugate Vaccine (PCV-7) Era.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. STEED ME , Vidaillac C, Rybak MJ
    Evaluation of Telavancin Activity versus Daptomycin and Vancomycin Against Daptomycin Non-Susceptible Staphylococcus aureus in an in vitro Pharmacokinetic/Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. FALORD M , Karimova G, Hiron A, Msadek T, et al
    GraXSR Interact With The VraFG ABC Transporter to Form a Five-Component System Required for Cationic Antimicrobial Peptide Sensing and Resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. TRAN PL , Lowry N, Campbell T, Reid TW, et al
    An Organoselenium Compound Inhibits Staphylococcus aureus Biofilms on Hemodialysis Catheters in Vivo.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. DOMINGUEZ-HERRERA J , Docobo-Perez F, Lopez-Rojas R, Pichardo C, et al
    Efficacy of daptomycin versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producers and methicillin-resistant Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. BROWN J , Brown K, Forrest A
    Vancomycin AUC24/MIC in MRSA Complicated Bacteremia and Infective Endocarditis Patients and its Association with Attributable Mortality during Hospitalization.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. WARN PA , Livermore J, Howard S, Felton TW, et al
    Anidulafungin for Neonatal Hematogenous Candida Meningoencephalitis: Identification of Candidate Regimens for Humans Using a Translational Pharmacological Approach.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. YU LH , Wei X, Ma M, Chen XJ, et al
    Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. GRAU T , Selchow P, Tigges M, Burri R, et al
    Phenylethyl-butyrate enhances the potency of second-line drugs against clinical isolates of M. tuberculosis.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. ELLIS D , Gosai J, Emrick C, Heintz R, et al
    Occidiofungin's Chemical Stability and In vitro Potency Against Candida species.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. REISS S , Pane-Farre J, Fuchs S, Francois P, et al
    Global analysis of the Staphylococcus aureus response to mupirocin.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. MILLER LG , Tan J, Eells SJ, Benitez E, et al
    A Prospective Investigation of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Community-Associated Methicillin Resistant Staphylococcus aureus Infections.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. NICASIO AM , Bulitta JB, Lodise TP, D'Hondt RE, et al
    Evaluation of once-daily vancomycin against methicillin-resistant Staphylococcus aureus in a hollow fiber infection model.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. MELETIADIS J , Al-Saigh R, Velegraki A, Walsh TJ, et al
    Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. STUCKI A , Cottagnoud M, Acosta F, Egerman U, et al
    Evaluation of Ceftobiprole against a Variety of Gram-Negative Pathogens including Escherichia coli, Haemophilus influenzae (beta-Lactamase Positive and beta-Lactamase Negative) and Klebsiella pneumoniae, in a Rabbit Meningitis Model.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. DRAPER LA , Tagg JR, Hill C, Cotter PD, et al
    The spiFEG locus in Streptococcus infantarius subsp. infantarius BAA-102 confers protection against nisin U.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. LEBEAUX D , Barbier F, Angebault C, Ben Mahdi L, et al
    Evolution of Methicillin-Resistant Coagulase-Negative Staphylococci Nasal Carriage in a Remote Population.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. RODRIGUEZ CA , Agudelo M, Zuluaga AF, Vesga O, et al
    Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in the neutropenic mouse thigh infection model.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. FINK SL , Martinello RA, Campbell SM, Murray TS, et al
    Low Prevalence of Heterogeneous Vancomycin Intermediate Staphylococcus aureus among Connecticut Veterans.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
53. TELES C , Smith A, Lang S
    Antibiotic modulation of the plasminogen binding ability of viridians group streptococci.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. TASHIRO M , Izumikawa K, Minematsu A, Hirano K, et al
    Antifungal susceptibilities of Aspergillus fumigatus clinical isolates in Nagasaki, Japan.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. LOCKE JB , Rahawi S, Lamarre J, Mankin AS, et al
    Genetic Environment and Stability of cfr in Methicillin-Resistant Staphylococcus aureus CM05.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. HAGIHARA M , Wiskirchen DE, Kuti JL, Nicolau DP, et al
    In Vitro Pharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. BLOSSER SJ , Cramer RA
    SREBP Dependent Triazole Susceptibility in Aspergillus fumigatus is Mediated Through Direct Transcriptional Regulation of erg11A/cyp51A.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. DHAMGAYE S , Devaux F, Manoharlal R, Vandeputte P, et al
    In vitro effect of Malachite Green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. ESCRIBANO P , Recio S, Pelaez T, Gonzalez-Rivera M, et al
    In Vitro Acquisition of Secondary Azole Resistance in Aspergillus fumigatus Isolates After Prolonged Exposure to Itraconazole: Presence of Heteroresistant Populations.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. YAO X , Lu CD
    A PBP2 Mutant Devoid of the Transpeptidase Domain Abolishes Spermine/{beta}-Lactam Synergy in Staphylococcus aureus Mu50.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. CAMPS SM , van der Linden JW, Li Y, Kuijper EJ, et al
    Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. GRIFFITHS JM , O'Neill AJ
    Loss of function of the GdpP protein leads to joint {beta}-lactam/glycopeptide tolerance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. GIOVANETTI E , Brenciani A, Tiberi E, Bacciaglia A, et al
    ICESp2905, the erm(TR)-tet(O) element of Streptococcus pyogenes, is formed by two independent ICEs.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MICELI MH , Bernardo SM, Ku TS, Walraven C, et al
    In vitro analyses of the effect of heparin and parabens on Candida albicans biofilms and planktonic cells.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. LEE KK , Maccallum DM, Jacobsen MD, Walker LA, et al
    Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. KJELLSSON MC , Via LE, Goh A, Weiner D, et al
    Penetration of anti-tuberculosis agents in rabbit pulmonary lesions: a pharmacokinetic evaluation.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. SEIDL K , Chen L, Bayer AS, Hady WA, et al
    Relationship of agr Expression and Function with Virulence and Vancomycin Treatment Outcomes in Experimental Endocarditis due to Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. CHEN HJ , Tsai JC, Hung WC, Tseng SP, et al
    Identification of fusB-mediated Fusidic Acid Resistance Islands in Staphylococcus epidermidis Isolates.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. HEYSELL SK , Mtabho C, Mpagama S, Mwaigwisya S, et al
    A plasma drug activity assay for treatment optimization in tuberculosis patients.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. THEE S , Seddon JA, Donald PR, Seifar HI, et al
    PHARMACOKINETICS OF ISONIAZID, RIFAMPICIN AND PYRAZINAMIDE IN CHILDREN YOUNGER THAN TWO YEARS OF AGE WITH TUBERCULOSIS; EVIDENCE FOR IMPLEMENTATION OF REVISED WORLD HEALTH ORGANIZATION RECOMMENDATIONS.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. ALLIZOND V , Banche G, Giacchino F, Merlino C, et al
    CANDIDA ALBICANS INFECTIONS IN RENAL TRANSPLANT RECIPIENTS: EFFECT OF CASPOFUNGIN ON POLYMORPHONUCLEAR CELLS.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. OLSON JA , Schwartz J, Hahka D, George A, et al
    Differences in Efficacy and Cytokine Profiles following Echinocandin or Liposomal Amphotericin B Monotherapy or Combination Therapy for Murine Pulmonary or Systemic Aspergillus flavus Infections.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
73. GOHRING N , Fedtke I, Xia G, Jorge AM, et al
    New role of the disulfide stress effector YjbH in Staphylococcus aureus {beta}-lactam susceptibility.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. MELLADO E , Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL, et al
    Role of Aspergillus lentulus 14-{alpha} sterol demethylase (cyp51A) in azole drugs susceptibility.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. BUTTERFIELD J , Tsuji B, Brown J, Dodds Ashley E, et al
    Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections in the "15-20 mg/L" target vancomycin trough era.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. TASNEEN R , Li SY, Peloquin CA, Taylor D, et al
    Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. FEUERRIEGEL S , Koser CU, Bau D, Rusch-Gerdes S, et al
    Impact of fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. ESCUDERO JA , San Millan A, Gutierrez B, Hidalgo L, et al
    Fluoroquinolone efflux in Streptococcus suis is mediated by SatAB and not by SmrA.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. CHANG Y , Chen WC, Hsieh PH, Chen DW, et al
    The In Vitro Activities of Daptomycin-, Vancomycin-, and Teicoplanin-loaded Polymethylmethacrylate against Methicillin-susceptible, Methicillin-Resistant and Vancomycin-Intermediate Strains of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. CADENA J , Nair S, Henao-Martinez AF, Jorgensen JH, et al
    Dose of Trimethoprim-Sulfamethoxazole to Treat Skin and Skin Structure Infections Caused by Methicillin Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. CANTON E , Peman J, Quindos G, Eraso E, et al
    Epidemiology, Molecular Identification and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis Isolated from Patients with Candidemia: Prospective Multicenter Study.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. DAI T , Bil de Arce VJ, Tegos GP, Hamblin MR, et al
    Blue dye and red light: a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. ALI A , Hasan R, Jabeen K, Jabeen N, et al
    Characterization of mutations conferring extensive drug resistance to M. tuberculosis isolates in Pakistan.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. CORNELY OA , Vehreschild JJ, Vehreschild MJ, Wurthwein G, et al
    A phase II dose escalation study of caspofungin for invasive aspergillosis.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. FERNANDEZ J , Hilliard JJ, Morrow BJ, Melton JL, et al
    Studies of the Efficacy of a New Fluoroquinolone, JNJ-Q2, in Skin, Respiratory, and Systemic Murine Models of Staphylococcus aureus and Streptococcus pneumoniae Infection.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. STERGIOPOULOU T , Meletiadis J, Seiin T, Papaioannidou P, et al
    Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin and polymorphonuclear neutrophils against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. SRIVASTAVA S , Sherman C, Meek C, Leff R, et al
    Pharmacokinetic mismatch does not lead to emergence of isoniazid or rifampin-resistant Mycobacterium tuberculosis, but better antimicrobial effect: a new paradigm for anti-tuberculosis drug scheduling.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. PEA F , Cojutti P, Petrosillo N, Furlanut M, et al
    Continuous Infusion May Improve the Efficacy of Vancomycin in Treatment of Experimental Endocarditis Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011;55:4496-7.
    PubMed     Text format     Related articles   
    
    
    
    
89. ANGEBY K , Giske CG, Jureen P, Schon T, et al
    Wild-Type MIC Distributions Must Be Considered To Set Clinically Meaningful Susceptibility Testing Breakpoints for All Bacterial Pathogens, Including Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2011;55:4492-3.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
90. CRISMARU M , Asri LA, Loontjens TJ, Krom BP, et al
    Survival of Adhering Staphylococci during Exposure to a Quaternary Ammonium Compound using AFM imaging.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. AL-BARRAG A , Anderson MJ, Howard SJ, Robson GD, et al
    Interrogation of related Clinical Pan-azole Resistant Aspergillus fumigatus strains - G138C, Y431C and G434C SNPs in cyp51A, Upregulation of cyp51A and Integration and Activation of Transposon Atf1 into cyp51A Promoter.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. LAZAREV VN , Polina NF, Shkarupeta MM, Kostrjukova ES, et al
    SPIDER VENOM PEPTIDES FOR GENE THERAPY OF Chlamydia INFECTION.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. ESPINEL-INGROFF A , Cuenca-Estrella M, Fothergill A, Fuller J, et al
    Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 document).
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. BLANCHARD E , Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, et al
    PRIOR CASPOFUNGIN EXPOSURE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IS A RISK FACTOR FOR SUBSEQUENT FUNGEMIA DUE TO DECREASED SUSCEPTIBLE CANDIDA SPP.: A CASE-CONTROL STUDY IN PARIS, FRANCE.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. POEPPL W , Tobudic S, Lingscheid T, Plasenzotti R, et al
    Daptomycin, Fosfomycin, or Both for Treatment of Methicillin-Resistant Staphylococcus aureus Osteomyelitis in an Experimental Rat Model.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. XIONG YQ , Abdel Hady W, Deslandes A, Rey A, et al
    Efficacy of NZ2114, a Novel Plectasin-Derived Cationic Antimicrobial Peptide Antibiotic, in Experimental Endocarditis due to Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. SALAS V , Pastor FJ, Calvo E, Mayayo E, et al
    Anidulafungin in the treatment of experimental invasive infection by Candida parapsilosis: in vitro activity, (1->3)-{beta}-D-glucan and mannan serum levels, histopathological findings, and in vivo efficacy.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. LU Y , Zheng M, Wang B, Fu L, et al
    Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. MAI J , Tian XL, Gallant JW, Merkley N, et al
    A Novel Target-Specific, Salt-Resistant Antimicrobial Peptide against the Cariogenic Pathogen Streptococcus mutans.
    Antimicrob Agents Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. PFALLER MA , Duncanson F, Messer SA, Moet GJ, et al
     In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. as determined by CLSI and EUCAST broth microdilution methods.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. LAMERS RP , Eade CR, Waring AJ, Cole AL, et al
     Characterization of the retrocyclin analogue RC-101 as a preventative of Staphylococcus aureus nasal colonization.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. LEE S , Choe PG, Song KH, Park SW, et al
     Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. LIEVIN-LE MOAL V , Amsellem R, Servin AL
     Impairment of Swimming Motility by Antidiarrheic Lactobacillus acidophilus Strain LB Retards Internalization of Salmonella enterica serovar Typhimurium Within Human Enterocyte-like Cells.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. MOORE CL , Lu M, Cheema F, Osaki-Kiyan P, et al
     Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Clinically Useful Risk Stratification Tool.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. SALEH-MGHIR A , Muller-Serieys C, Dinh A, Massias L, et al
     Rifampin Adjunction Is Crucial to Optimizing Daptomycin Efficacy against Methicillin-Resistant Staphylococcus aureus Rabbit Prosthetic Joint Infection.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. HEYSELL SK , Houpt ER
     Optimizing second-line therapy for drug-resistant tuberculosis: the additive value of sequencing for multiple resistance Loci.
     Antimicrob Agents Chemother. 2011;55:3968-9.
     PubMed     Text format     Related articles   
     
     
     
     
107. LEBRETON F , Depardieu F, Bourdon N, Fines-Guyon M, et al
     D-Ala-D-Ser VanN-type Transferable Vancomycin Resistance in Enterococcus faecium.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. FURUSTRAND U , Majic I, Belkhodja Zalila C, Betrisey B, et al
     Gentamicin improves the activity of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. ROSSIGNOL T , Kelly B, Dobson C, d'Enfert C, et al
     Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. HOWARD SJ , Slater J, Sharp A, Goodwin J, et al
     Pharmacodynamics of Echinocandins against Candida glabrata: Requirement For Dosage Escalation to Achieve Maximal Antifungal Activity in Neutropenic Hosts.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2011
111. QUINTERO B , Araque M, van der Gaast-de Jongh C, Hermans PW, et al
     GENETIC DIVERSITY OF Tn916-RELATED TRANSPOSONS AMONG DRUG-RESISTANT STREPTOCOCCUS PNEUMONIAE ISOLATES COLONIZING HEALTHY CHILDREN IN VENEZUELA.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. HATA K , Horii T, Miyazaki M, Watanabe NA, et al
     Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and Fusariosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. STEED ME , Vidaillac C, Rose WE, Winterfield P, et al
     Characterizing vancomycin resistant Enterococcus (VRE) strains with varying daptomycin (DAP) resistance developed in an in vitro Pharmacokinetic/Pharmacodynamic model.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. DOMENECH DE CELLES M , Opatowski L, Salomon J, Varon E, et al
     Intrinsic Epidemicity of Streptococcus pneumoniae Depends on Strain Serotype and Antibiotic-Susceptibility Pattern.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. CHANG KC , Yew WW, Zhang Y
     Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. SHARMA M , Prasad R
     The quorum sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. HOWARD SJ , Harrison E, Bowyer P, Varga J, et al
     Cryptic species and azole resistance in the Aspergillus niger complex.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. PANTEL A , Petrella S, Matrat S, Brossier F, et al
     DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. BINK A , Vandenbosch D, Coenye T, Nelis H, et al
     SUPEROXIDE DISMUTASES ARE INVOLVED IN CANDIDA ALBICANS BIOFILM PERSISTENCE TO MICONAZOLE.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. IDELEVICH EA , von Eiff C, Friedrich AW, Iannelli D, et al
     In Vitro Activity of a Novel Antimicrobial Agent PRF-119 - a Recombinant Chimeric Bacteriophage Endolysin against Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. WACHTLER B , Wilson D, Hube B
     Candida albicans adhesion, invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. DOMENECH M , Garcia E, Moscoso M
     In vitro Destruction of Streptococcus pneumoniae Biofilms with Bacterial and Phage Peptidoglycan Hydrolases.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. GHANNOUM MA , Isham N, Jacobs MR
     ANTIMICROBIAL ACTIVITY OF B-LOCKTM AGAINST BACTERIA AND CANDIDA CAUSING CATHETER-RELATED BLOODSTREAM INFECTIONS.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. ENTENZA JM , Veloso TR, Vouillamoz J, Giddey M, et al
     In vivo Synergism of Ceftobiprole and Vancomycin Against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2011
125. MISHRA NN , McKinnell J, Yeaman MR, Rubio A, et al
     In Vitro Cross-Resistance of Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. PROJAHN M , Koser CU, Homolka S, Summers DK, et al
     Polymorphisms in isoniazid and prothionamide resistance genes of the Mycobacterium tuberculosis complex.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. VAN PRAAGH AD , Li T, Zhang S, Arya A, et al
     Daptomycin Antibiotic-Lock Therapy in a Rat Model of Staphylococcal Central Venous Catheter Biofilm Infections.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. RICHTER SS , Heilmann KP, Dohrn CL, Riahi F, et al
     Activity of Ceftaroline and Epidemiologic Characterization of Staphylococcus aureus From 43 Medical Centers in the United States, 2009.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. MANNING L , Laman M, Greenhill A, Michael A, et al
     Increasing chloramphenicol resistance in Streptococcus pneumoniae isolates from Papua New Guinean children with acute bacterial meningitis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. YAMASHITA H , Tomita H, Inoue T, Ike Y, et al
     Genetic Organization and Mode of Action of a Novel Bacteriocin 51 (Bac 51): Determinant of VanA Type Vancomycin Resistant Enterococcus faecium (VRE).
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. LOCKHART SR , Frade JP, Etienne KA, Pfaller MA, et al
     Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. JONSSON S , Davidse A, Wilkins J, Van der Walt JS, et al
     Population pharmacokinetics of ethambutol in South African tuberculosis patients.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. LOCKHART SR , Zimbeck AJ, Baddley JW, Marr KA, et al
     In vitro susceptibility of Aspergillus to echinocandins: Isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. KEEL RA , Crandon JL, Nicolau DP
     Efficacy of Human Simulated Exposures of Ceftaroline 600mg q12h against Phenotypically Diverse Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. YAMAKI J , Synold T, Wong-Beringer A
     Anti-virulence Potential of TR-700 and Clindamycin on Clinical Isolates of Staphylococcus aureus producing Phenol-Soluble Modulins.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. DAMBORG P , Bartels MD, Boye K, Guardabassi L, et al
     Structural variations of staphylococcal cassette chromosome mec type IVa in Staphylococcus aureus clonal complex 8 and unrelated lineages.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. KIM H , Nakajima C, Yokoyama K, Rahim Z, et al
     Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosison Quinolone Resistance.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. SHORE AC , Deasy EC, Slickers P, Brennan G, et al
     Detection of Staphylococcal Cassette Chromosome mec Type XI Encoding Highly Divergent mecA, mecI, mecR1, blaZ and ccr Genes in Human Clinical Clonal Complex 130 Methicillin-Resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2011
139. PATEL SN , McGeer A, Melano R, Tyrrell GJ, et al
     Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. SHOJI M , Cui L, Iizuka R, Komoto A, et al
     The walK and clpP Mutations Confer Reduced Vancomycin Susceptibility on Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. VILCHEZE C , Baughn AD, Tufariello J, Leung L, et al
     Novel inhibitors of InhA efficiently kill Mycobacterium tuberculosis under aerobic and anaerobic conditions.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. HEALEY KR , Katiyar SK, Castanheira M, Pfaller MA, et al
     Candida glabrata Mutants Demonstrating Paradoxical Caspofungin Reduced Susceptibility but Micafungin Increased Susceptibilty.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. WINGARD JB , Romanowski EG, Kowalski RP, Mah FS, et al
     A novel Cell-Associated Protection Assay (CAPA) demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. FOO DG , Tay HC, Siew JY, Singhal A, et al
     T cell monitoring of chemotherapy in experimental rat tuberculosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. BERTSCHE U , Weidenmaier C, Kuehner D, Yang SJ, et al
     Correlation of Daptomycin-Resistance in a Clinical Staphylococcus aureus Strain with Increased Cell Wall Teichoic Acid Production and D-alanylation.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. GALLOWAY-PENA JR , Rice LB, Murray BE
     Analysis of PBP5 of Early United States Enterococcus faecium Isolates: Sequence Variation Alone Does Not Explain Increasing Ampicillin Resistance Over Time.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. YU L , Ling G, Deng X, Jin J, et al
     In Vitro Interaction between Fluconazole and Triclosan against Clinical Isolates of Fluconazole-Resistant Candida albicans Determined by Different Methods.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. STEED M , Vidaillac C, Rybak MJ
     Evaluation of Ceftaroline (CPT) Activity versus Daptomycin (DAP) Against DAP Non-Susceptible Methicillin-Resistant Staphylococcus aureus (MRSA) Strains in an In-Vitro Pharmacokinetic/Pharmacodynamic Model.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. JOHN AK , Schmaler M, Khanna N, Landmann R, et al
     Reversible daptomycin tolerance of adherent staphylococci in an implant infection model.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. SCHAAR V , Nordstrom T, Morgelin M, Riesbeck K, et al
     Moraxella catarrhalis outer membrane vesicles carry beta-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. RAMON-GARCIA S , Ng C, Anderson H, Chao JD, et al
     Synergistic drug combinations for tuberculosis therapy identified by a novel high throughput screen.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. SEKIGUCHI JI , Disratthakit A, Maeda S, Doi N, et al
     Characteristic Resistance Mechanism of DC-159a, a New Respiratory Quinolone, in Mycobacterium tuberculosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. FARRELL DJ , Liverman LC, Biedenbach DJ, Jones RN, et al
     JNJ-Q2: a New Fluoroquinolone with Potent in Vitro Activity against Staphylococcus aureus, Including Methicillin- and Fluoroquinolone-resistant Strains.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. SHIELDS RK , Nguyen MH, Press E, Clancy CJ, et al
     Five-minute exposure to caspofungin results in prolonged post-antifungal effects and eliminates the paradoxical growth of Candida albicans.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
155. CHANCEY S , Zhou X, Zahner D, Stephens DS, et al
     Induction of efflux-mediated macrolide resistance in Streptococcus pneumoniae.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
156. VIGNAROLI C , Rinaldi C, Varaldo PE, Lee CH, et al
     Striking "Seesaw Effect" between Daptomycin Nonsusceptibility and {beta}-Lactam Susceptibility in Staphylococcus haemolyticus.
     Antimicrob Agents Chemother. 2011;55:2495-7.
     PubMed     Text format     Related articles   
     
     
     
     April 2011
157. BRENA S , Cabezas-Olcoz J, Moragues MD, Fernandez de Larrinoa I, et al
     Fungicidal Monoclonal Antibody C7 Interferes with Iron Acquisition in Candida albicans.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
158. SILVA AP , Miranda IM, Guida A, Synnott J, et al
     Transcriptional profiling of azole-resistant Candida parapsilosis strains.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
159. UPPULURI P , Srinivasan A, Ramasubramanian A, Lopez-Ribot JL, et al
     Effect of Fluconazole, Amphotericin B and Caspofungin against Candida albicans Biofilms under Conditions of Flow and on Biofilm Dispersion.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
160. DUMITRESCU O , Choudhury P, Boisset S, Badiou C, et al
     Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering SarA and rot global regulators of Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. WIEDERHOLD NP , Najvar LK, Bocanegra R, Kirkpatrick WR, et al
     Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. HASTE NM , Hughes CC, Tran DN, Fenical W, et al
     Pharmacological Properties of the Marine Natural Product Marinopyrrole A Against Methicillin-Resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. SLATER JL , Howard SJ, Sharp A, Goodwin J, et al
     Disseminated candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. KUIPERS S , Bruggemann RJ, de Sevaux RG, Heesakkers JP, et al
     Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. PALACIO F , Lewis JS 2nd, Sadkowski L, Echevarria K, et al
     Breakthrough Bacteremia and Septic Shock Due to Streptococcus anginosus Resistant to Daptomycin in a Patient Receiving Daptomycin Therapy.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. THWAITES GE , Bhavnani SM, Thi Hong Chau T, Hammel JP, et al
     A randomised pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. PALMER KL , Daniel A, Hardy C, Silverman J, et al
     Genetic basis for daptomycin resistance in enterococci.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. ZELENITSKY S , Alkurdi N, Weber Z, Ariano R, et al
     Preferential Emergence of Reduced Vancomycin Susceptibility in Healthcare-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) during Continuous Infusion Vancomycin Therapy (CIV) in an In Vitro Dynamic Model.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. LOUIE A , Liu W, Kulawy R, Drusano GL, et al
     In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus In a Mouse Thigh Infection Model.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. DEL GROSSO M , Camilli R, Barbabella G, Blackman Northwood J, et al
     Genetic resistance elements carrying mef subclasses other than mef(A) in Streptococcus pyogenes.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. KOSER CU , Summers DK, Archer JA
     Thr270Ile in embC (Rv3793) Is Not a Marker for Ethambutol Resistance in the Mycobacterium tuberculosis Complex.
     Antimicrob Agents Chemother. 2011;55:1825.
     PubMed     Text format     Related articles   
     
     
     
     
172. CHLEBOWICZ MA , van Dijl JM, Buist G
     Considerations for the Distinction of ccrC-Containing Staphylococcal Cassette Chromosome mec Elements.
     Antimicrob Agents Chemother. 2011;55:1823-4.
     PubMed     Text format     Related articles   
     
     
     
     March 2011
173. WONG SY , Lee JS, Kwak HK, Via LE, et al
     Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. PLINKE C , Walter K, Aly S, Ehlers S, et al
     Mycobacterium tuberculosis embB306 mutations confer moderately increased resistance to Ethambutol in vitro and in vivo.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. TRABOULSI RS , Mukherjee PK, Chandra J, Salata RA, et al
     Gentian Violet Exhibits Activity against Biofilms formed by Oral Candida isolates Obtained from HIV-infected Patients.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. ARABATZIS M , Kambouris M, Kyprianou M, Chrysaki A, et al
     Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. LAMARRE JM , Howden BP, Mankin AS
     Inactivation of the indigenous methyltransferase RlmN in Staphylococcus aureus increases linezolid resistance.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. SHIELDS RK , Nguyen MH, Du C, Press E, et al
     Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways, but eliminated in human serum.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. CHEN YN , Lo HJ, Wu CC, Ko HC, et al
     Loss-of-Heterozygosity of FCY2 Leading to the Development of Flucytosine Resistance in Candida tropicalis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. ESPINEL-INGROFF A , Fothergill A, Fuller J, Johnson E, et al
     Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 document).
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. FIORI B , Posteraro B, Torelli R, Tumbarello M, et al
     In vitro activity of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. LI S , Skov RL, Han X, Larsen AR, et al
     Novel types of staphylococcal cassette chromosome mec elements identified in CC398 methicillin resistant Staphylococcus aureus strains.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. TRAN TD , Kwon HY, Kim EH, Kim KW, et al
     Decrease In Penicillin Susceptibility by Heat Shock Protein ClpL in Streptococcus pneumoniae.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. SCHUBERT S , Barker KS, Znaidi S, Schneider S, et al
     Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
185. LIU C , Worthington RJ, Melander C, Wu H, et al
     A new small-molecule specifically inhibits the cariogenic Streptococcus mutans in multispecies biofilms.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. MORIYAMA B , Ditullio M, Wilson E, Henning SA, et al
     Pharmacokinetics of Anidulafungin in Pleural Fluid During the Treatment of a Patient with Candida Empyema.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
187. LONGTIN J , Seah C, Siebert K, McGeer A, et al
     Distribution of antiseptic-resistance genes qacA/B and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, 2005-2009.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. PEREZ-TRALLERO E , Marimon JM, Larruskain J, Alonso M, et al
     Antimicrobial susceptibility and serotypes of Streptococcus pneumoniae isolated from elderly patients with pneumonia and acute exacerbation of COPD.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
189. BOBBA S , Ponnaluri VK, Mukherji M, Gutheil WG, et al
     A Microtiter Plate-Based Assay for Inhibitors of Penicillin-Binding Protein 2a from Methicillin Resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
190. VEZIRIS N , Truffot C, Mainardi JL, Jarlier V, et al
     Activity of carbapenems combined with clavulanate in murine tuberculosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. GARCIA-EFFRON G , Park S, Perlin DS
     Improved detection of Candida spp. fks hot spot mutants using the CLSI M27-A3 Document by the addition of Bovine Serum Albumin (BSA).
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
192. JO DS , Montgomery CP, Yin S, Boyle-Vavra S, et al
     Improved Oxacillin Treatment Outcomes in Experimental Skin and Lung Infection by Methicillin-Resistant Staphylococcus aureus Containing a vraSR Operon Deletion.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
193. LONGTIN J , Vermeiren C, Shahinas D, Tamber GS, et al
     Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long term oral suppressive therapy.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
194. RODRIGUEZ-AVIAL I , Ramos B, Rios E, Cercenado E, et al
     Clonal Spread of Levofloxacin-resistant Streptococcus pneumoniae Invasive Isolates in Madrid, Spain (2007-2009).
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
195. ZORAGHI R , See RH, Axerio-Cilies P, Kumar NS, et al
     Identification of Methicillin Resistant Staphylococcus aureus Pyruvate Kinase as a Novel Antimicrobial Drug Target.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. DIDIER JP , Villet R, Huggler E, Lew DP, et al
     Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
197. MITCHELL G , Gattuso M, Grondin G, Marsault E, et al
     Tomatidine Inhibits the Replication of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Airway Epithelial Cells.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. ARENDRUP MC , Park S, Brown S, Pfaller M, et al
     Evaluation of Caspofungin and Micafungin CLSI M44-A2 Disk Diffusion and associated breakpoints testing using a well characterized panel of wild type and fks hot spot mutant Candida isolates.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
199. IKEDA-DANTSUJI Y , Hanaki H, Nakae T, Takesue Y, et al
     Emergence of linezolid-resistant mutants in the susceptible cell population of methicillin-resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
200. CHATZIMOSCHOU A , Katragkou A, Simitsopoulou M, Antachopoulos C, et al
     Activities of Triazole-Echinocandin Combinations against Candida Species in Biofilms and as Planktonic Cells.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
201. TARRAGO D , Aguilar L, Garcia R, Gimenez MJ, et al
     Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain (1990-2008).
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
202. BRENCIANI A , Tiberi E, Bacciaglia A, Petrelli D, et al
     Two Distinct Genetic Elements Are Responsible for erm(TR)-Mediated Erythromycin Resistance in Tetracycline-Susceptible and Tetracycline-Resistant Strains of Streptococcus pyogenes.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
203. LIANG B , Bai N, Cai Y, Wang R, et al
     MPC-based PK/PD indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
204. MOGAVERO S , Tavanti A, Senesi S, Rogers PD, et al
     Differential requirement of the transcription factor Mcm1 for activation of the Candida albicans multidrug efflux pump MDR1 by its regulators Mrr1 and Cap1.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
205. PEREZ-TRALLERO E , Tamayo E, Montes M, Garcia-Arenzana JM, et al
     In vitro activity of retapamulin and other 16 antimicrobial agents against recently isolated Streptococcus pyogenes.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
206. MCGHEE P , Clark C, Credito K, Beachel L, et al
     In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolated from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
207. SHORE AC , Rossney AS, Brennan OM, Kinnevey PM, et al
     Characterization of a Novel Arginine Catabolic Mobile Element (ACME) and Staphylococcal Chromosomal Cassette mec Composite Island with Significant Homology to Staphylococcus epidermidis ACME type II in Methicillin-Resistant Staphylococcus aureus Genot
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
208. VIDAILLAC C , Steed ME, Rybak MJ
     Impact of dose de-escalation and escalation on daptomycin'spharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitromodel.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. FERRARI S , Sanguinetti M, De Bernardis F, Torelli R, et al
     Loss of mitochondrial functions associated with azole resistance in Candida glabrata also results in enhanced virulence in mice.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
210. ESCRIBANO P , Recio S, Pelaez T, Bouza E, et al
     Aspergillus fumigatus Strains With Mutations in the cyp51A Gene Do Not Always Show Phenotypic Resistance to Itraconazole, Voriconazole, or Posaconazole.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
211. SHIMA K , Szaszak M, Solbach W, Gieffers J, et al
     Impact of a low oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
212. RAJENDRAN R , Mowat E, McCulloch E, Lappin DF, et al
     Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
213. BLAKE KL , Randall CP, O'Neill AJ
     In vitro studies indicate a high resistance potential for the lantibiotic nisin in Staphylococcus aureus and define a genetic basis for nisin resistance.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
214. CAMPBELL PJ , Morlock GP, Sikes RD, Dalton TL, et al
     Molecular Detection of Mutations Associated with First and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing in M. tuberculosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
215. FRACZEK MG , Bromley M, Bowyer P
     An improved model of the Aspergillus fumigatus CYP51A protein.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
216. CHATURVEDI V , Ramani R, Andes D, Diekema DJ, et al
     Multi-laboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
217. BISWAS S , Biswas I
     ROLE OF VLTAB, AN ABC TRANSPORTER COMPLEX, IN VIOLOGEN TOLERANCE IN STREPTOCOCCUS MUTANS.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
218. EGUCHI Y , Kubo N, Matsunaga H, Igarashi M, et al
     Development of anti-virulence drug in Streptococcus mutans: repression of biofilm formation, acid tolerance, and competence by a histidine kinase inhibitor, Walkmycin C.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
219. AHMAD Z , Fraig MM, Bisson GP, Nuermberger EL, et al
     Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
220. LIGNELL A , Lowdin E, Cars O, Sanglard D, et al
     Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
221. MIYAZAKI M , Takata T, Yoshimura H, Matsunaga A, et al
     Vancomycin Bactericidal Activity as a predictor of 30-day mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
222. SANDBERG A , Lemaire S, Van Bambeke F, Tulkens PM, et al
     Intra- and extracellular activity of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with small-colony variant phenotype in an in vitro (THP-1 macrophages) and an in vivo (mouse peritonitis) model.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
223. SINGH M , Mukhopadhyay K
     C-terminal amino acids of alpha-melanocyte stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
224. MCNEIL JC , Hulten KG, Kaplan SL, Mason EO, et al
     Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
225. AHMAD Z , Minkowski A, Peloquin CA, Williams KN, et al
     Activity of the fluoroquinolone DC-159a in the initial and continuation phase treatment of murine tuberculosis.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
226. CUENCA-ESTRELLA M , Gomez-Lopez A, Cuesta I, Zaragoza O, et al
     Frequency of Resistance In Vitro to Voriconazole among Spanish Clinical Isolates of Candida spp. According to Breakpoints by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
227. IBRAHIM AS , Gebremariam T, Luo G, Fu Y, et al
     Combination Therapy of Murine Mucormycosis or Aspergillosis with Iron Chelation, Polyenes and Echinocandins.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
228. MINGOIA M , Tili E, Manso E, Varaldo PE, et al
     Heterogeneity of Tn5253-Like Composite Elements in Clinical Streptococcus pneumoniae Isolates.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
229. ENDIMIANI A , Blackford M, Dasenbrook EC, Reed MD, et al
     Emergence of Linezolid-Resistant Staphylococcus aureus after prolonged treatment of Cystic Fibrosis Patients in Cleveland.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
230. MAUDSDOTTER L , Jonsson H, Roos S, Jonsson AB, et al
     Lactobacilli Reduce Cell Cytotoxicity Caused by Streptococcus pyogenes by Producing Lactic Acid that Degrades the Toxic Component Lipoteichoic Acid.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
231. MALBRUNY B , Werno AM, Murdoch DR, Leclercq R, et al
     Cross-Resistance to Lincosamides, Streptogramins A, and Pleuromutilins Due to the lsa(C) Gene in Streptococcus agalactiae UCN70.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
232. ARENDRUP MC , Rodriguez-Tudela JL, Park S, Garcia-Effron G, et al
     Echinocandin susceptibility testing of Candida spp. using the EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: Analysis of the influence of Bovine Serum Albumin Supplementation, Storage Time and Drug Lots.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
233. LEE YS , Shin YP, Shin SH, Park S, et al
     Therapeutic Efficacy of Halocidin-Derived Peptide HG1 in a Mouse Model of Surgical Wound Infection with Methicillin-Resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
234. DE KRAKER ME , Wolkewitz M, Davey PG, Grundmann H, et al
     The clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin resistant Staphylococcus aureus bloodstream infections.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
235. ROBERT J , Tristan A, Cavalie L, Decousser JW, et al
     PVL-positive and TSST-1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
236. MCCALLUM N , Stutzmann Meier P, Heusser R, Berger-Bachi B, et al
     Mutational analyses of ORFs within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus.
     Antimicrob Agents Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: